128 related articles for article (PubMed ID: 33587980)
1. Parallel genome-wide RNAi screens identify lymphocyte-specific protein tyrosine kinase (LCK) as a targetable vulnerability of cell proliferation and chemoresistance in nasopharyngeal carcinoma.
Liew K; Yu GQS; Wei Pua LJ; Wong LZ; Tham SY; Hii LW; Lim WM; OuYong BM; Looi CK; Mai CW; Fei-Lei Chung F; Tan LP; Ahmad M; Soo-Beng Khoo A; Leong CO
Cancer Lett; 2021 Apr; 504():81-90. PubMed ID: 33587980
[TBL] [Abstract][Full Text] [Related]
2. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.
Zhao Y; Zhang J; Tian Y; Xue C; Hu Z; Zhang L
Drug Des Devel Ther; 2015; 9():4897-907. PubMed ID: 26345996
[TBL] [Abstract][Full Text] [Related]
3. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
[TBL] [Abstract][Full Text] [Related]
4. Exosomal ERp44 derived from ER-stressed cells strengthens cisplatin resistance of nasopharyngeal carcinoma.
Xia T; Tian H; Zhang K; Zhang S; Chen W; Shi S; You Y
BMC Cancer; 2021 Sep; 21(1):1003. PubMed ID: 34493236
[TBL] [Abstract][Full Text] [Related]
5. MEK inhibition by trametinib overcomes chemoresistance in preclinical nasopharyngeal carcinoma models.
Gong X; Fan L; Wang P
Anticancer Drugs; 2021 Oct; 32(9):978-985. PubMed ID: 34282746
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.
Chan KC; Chan LS; Ip JC; Lo C; Yip TT; Ngan RK; Wong RN; Lo KW; Ng WT; Lee AW; Tsao GS; Kahn M; Lung ML; Mak NK
Sci Rep; 2015 Apr; 5():9979. PubMed ID: 25897700
[TBL] [Abstract][Full Text] [Related]
7. Integrin α5 mediates intrinsic cisplatin resistance in three-dimensional nasopharyngeal carcinoma spheroids via the inhibition of phosphorylated ERK /caspase-3 induced apoptosis.
Ngaokrajang U; Janvilisri T; Sae-Ueng U; Prungsak A; Kiatwuthinon P
Exp Cell Res; 2021 Sep; 406(2):112765. PubMed ID: 34358523
[TBL] [Abstract][Full Text] [Related]
8. Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein/Hippo signaling pathway.
Li T; Li Y
Immunobiology; 2023 Mar; 228(2):152324. PubMed ID: 36608594
[TBL] [Abstract][Full Text] [Related]
9. Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation.
Aimjongjun S; Mahmud Z; Jiramongkol Y; Alasiri G; Yao S; Yagüe E; Janvilisri T; Lam EW
BMC Cancer; 2019 Nov; 19(1):1106. PubMed ID: 31727006
[TBL] [Abstract][Full Text] [Related]
10. ARC is highly expressed in nasopharyngeal carcinoma and confers X-radiation and cisplatin resistance.
Wu P; Tang Y; He J; Qi L; Jiang W; Zhao S
Oncol Rep; 2013 Oct; 30(4):1807-13. PubMed ID: 23877130
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor ATMIN facilitates chemoresistance in nasopharyngeal carcinoma.
Fang XL; Li QJ; Lin JY; Huang CL; Huang SY; Tan XR; He SW; Zhu XH; Li JY; Gong S; Qiao H; Li YQ; Liu N; Ma J; Zhao Y; Tang LL
Cell Death Dis; 2024 Feb; 15(2):112. PubMed ID: 38321024
[TBL] [Abstract][Full Text] [Related]
12. High NEK2 confers to poor prognosis and contributes to cisplatin-based chemotherapy resistance in nasopharyngeal carcinoma.
Xu H; Zeng L; Guan Y; Feng X; Zhu Y; Lu Y; Shi C; Chen S; Xia J; Guo J; Kuang C; Li W; Jin F; Zhou W
J Cell Biochem; 2019 Mar; 120(3):3547-3558. PubMed ID: 30295336
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin suppresses proliferation, migration and invasion of nasopharyngeal carcinoma cells in vitro by repressing the Wnt/β-catenin/Endothelin-1 axis via activating B cell translocation gene 1.
Yin P; Song G; Jiang Z
Cancer Chemother Pharmacol; 2018 May; 81(5):863-872. PubMed ID: 29536130
[TBL] [Abstract][Full Text] [Related]
14. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.
Yang GD; Huang TJ; Peng LX; Yang CF; Liu RY; Huang HB; Chu QQ; Yang HJ; Huang JL; Zhu ZY; Qian CN; Huang BJ
PLoS One; 2013; 8(10):e78355. PubMed ID: 24194922
[TBL] [Abstract][Full Text] [Related]
16. K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr virus (EBV)--associated nasopharyngeal carcinoma cells.
Ng YK; Wong EY; Lau CP; Chan JP; Wong SC; Chan AS; Kwan MP; Tsao SW; Tsang CM; Lai PB; Chan AT; Lui VW
Invest New Drugs; 2012 Feb; 30(1):48-58. PubMed ID: 20694504
[TBL] [Abstract][Full Text] [Related]
17. Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma.
Pua LJW; Mai CW; Chung FF; Khoo AS; Leong CO; Lim WM; Hii LW
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163030
[TBL] [Abstract][Full Text] [Related]
18. EBV-encoded miRNAs can sensitize nasopharyngeal carcinoma to chemotherapeutic drugs by targeting BRCA1.
Lung RW; Tong JH; Ip LM; Lam KH; Chan AW; Chak WP; Chung LY; Yeung WW; Hau PM; Chau SL; Tsao SW; Lau KM; Lo KW; To KF
J Cell Mol Med; 2020 Nov; 24(22):13523-13535. PubMed ID: 33074587
[TBL] [Abstract][Full Text] [Related]
19. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-101-3p inhibits nasopharyngeal carcinoma cell proliferation and cisplatin resistance through ZIC5 down-regulation by targeting SOX2.
Li T; Zhang G; Li W; Xiao J; Zhou Z; Tan G; Ai J
Biol Chem; 2023 Sep; 404(10):961-975. PubMed ID: 36752150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
